These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32431116)

  • 1. Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice.
    Weng W; Ge T; Wang Y; He L; Liu T; Wang W; Zheng Z; Yu L; Zhang C; Lu X
    Diabetes Metab J; 2020 Aug; 44(4):566-580. PubMed ID: 32431116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
    Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
    Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model.
    Shao M; Yu L; Zhang F; Lu X; Li X; Cheng P; Lin X; He L; Jin S; Tan Y; Yang H; Zhang C; Cai L
    Am J Physiol Endocrinol Metab; 2015 Jul; 309(1):E45-54. PubMed ID: 25968574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy.
    Cheng Y; Zhang J; Guo W; Li F; Sun W; Chen J; Zhang C; Lu X; Tan Y; Feng W; Fu Y; Liu GC; Xu Z; Cai L
    Free Radic Biol Med; 2016 Apr; 93():94-109. PubMed ID: 26849944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice.
    Wang W; Jiang S; Tang X; Cai L; Epstein PN; Cheng Y; Sun W; Xu Z; Tan Y
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165589. PubMed ID: 31678163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation.
    Zhang C; Shao M; Yang H; Chen L; Yu L; Cong W; Tian H; Zhang F; Cheng P; Jin L; Tan Y; Li X; Cai L; Lu X
    PLoS One; 2013; 8(12):e82275. PubMed ID: 24349242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the inhibitive effect of Catalpol on diabetic nephropathy.
    Chen J; Yang Y; Lv Z; Shu A; Du Q; Wang W; Chen Y; Xu H
    Life Sci; 2020 Sep; 257():118120. PubMed ID: 32693244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of FGF21 on diabetes-induced male germ cell apoptosis is associated with up-regulated testicular AKT and AMPK/Sirt1/PGC-1α signaling.
    Jiang X; Chen J; Zhang C; Zhang Z; Tan Y; Feng W; Skibba M; Xin Y; Cai L
    Endocrinology; 2015 Mar; 156(3):1156-70. PubMed ID: 25560828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
    Li F; Chen Y; Li Y; Huang M; Zhao W
    Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy.
    Meng F; Cao Y; Khoso MH; Kang K; Ren G; Xiao W; Li D
    Arch Biochem Biophys; 2021 Nov; 713():109063. PubMed ID: 34695409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.
    Yan X; Chen J; Zhang C; Zeng J; Zhou S; Zhang Z; Lu X; Chen J; Feng W; Li X; Tan Y
    Cardiovasc Diabetol; 2015 Jun; 14(1):77. PubMed ID: 27391008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC3 inhibition in diabetic mice may activate Nrf2 preventing diabetes-induced liver damage and FGF21 synthesis and secretion leading to aortic protection.
    Zhang J; Xu Z; Gu J; Jiang S; Liu Q; Zheng Y; Freedman JH; Sun J; Cai L
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E150-E162. PubMed ID: 29634312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
    Hong YA; Lim JH; Kim MY; Kim Y; Park HS; Kim HW; Choi BS; Chang YS; Kim HW; Kim TY; Park CW
    Antioxid Redox Signal; 2018 Jun; 28(17):1543-1561. PubMed ID: 29020797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.
    Zhang C; Huang Z; Gu J; Yan X; Lu X; Zhou S; Wang S; Shao M; Zhang F; Cheng P; Feng W; Tan Y; Li X
    Diabetologia; 2015 Aug; 58(8):1937-48. PubMed ID: 26040473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation.
    Yang Y; He X; Cheng R; Chen Q; Shan C; Chen L; Ma JX
    FASEB J; 2020 Jun; 34(6):8428-8441. PubMed ID: 32352602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
    Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effects of brown adipose tissue activation in diabetic mice.
    Cai YY; Zhang HB; Fan CX; Zeng YM; Zou SZ; Wu CY; Wang L; Fang S; Li P; Xue YM; Guan MP
    J Diabetes; 2019 Dec; 11(12):958-970. PubMed ID: 31020790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.